Plain-English translation of NCT06517901 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether two different techniques for performing prostate biopsies are equally good at detecting clinically significant prostate cancer. Both methods use an MRI scan to guide the biopsy, but they do it in slightly different ways: one uses computer software to fuse MRI and ultrasound images together, and the other uses the doctor's visual judgment and measurements to guide the biopsy needle. The study wants to find out which approach is better at finding cancer.
Right now, doctors aren't sure whether one biopsy technique is better than the other at detecting prostate cancer. Research so far has been mixed and not high quality enough to give doctors a clear answer. This larger, well-designed study should help determine which method works best.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo a prostate biopsy using one of the two methods being tested. Your doctor will have already done an MRI scan of your prostate before your biopsy appointment. During the biopsy itself, you'll receive either the computer-guided fusion technique or the doctor-guided cognitive technique to help collect tissue samples from the suspicious areas. The study team will then compare how well each method detected cancer and track your results.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States
Canada